Baseimmune
Healthcare AI
vaccine design / antigen design / immunotherapy
Series A
Baseimmune is a London-based biotech company that uses proprietary deep-learning and computational protein-design methods to create synthetic antigens and active immunotherapies, with an initial focus on future-proof vaccines for rapidly mutating infectious diseases and a newer expansion into fibrosis.
Company Details
- Website
- baseimmune.co.uk
- Headquarters
- London, United Kingdom
- Founded
- 2019
- Funding
- $16.1M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring